News archive

The Nordic Association for the publication of "Basic & Clinical Pharmacology & Toxicology" has awarded the BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology for 2018 to Professor Magnus Ingelman-Sundberg, Department of Physiology and Pharmacology, Karolinska Institutet.

The project "LST-STRATEGY – Strategies for large system transformations in a decentralized healthcare system" led by Monica Nyström at the Department of Learning, Informatics, Management and Ethics, MMC/SOLIID, receives funding from FORTE, the Swedish Research Council for Health, Working Life and Welfare.

Klas Kärre, member of the Nobel Committee and MTC research group leader comments on the on the life-changing possibilities of this year’s Nobel Prize in an interview with freelance journalist Lotta Fredholm.

This year’s Nobel Prize in Physiology or Medicine recognizes the discovery that it is possible to treat cancer by inhibiting the brakes on the immune system. Behind their discovery lies a bold idea and eager basic research, which has led to an entirely new principle for cancer therapy and new medicines that have already been approved. Many factors contribute to rapid developments in this field—in particular, current research at Karolinska Institutet.

The Nobel Assembly at Karolinska Institutet has today decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation.

Researchers at Karolinska Institutet have identified four types of neurons in the peripheral auditory system, three of which are new to science. The analysis of these cells can lead to new therapies for various kinds of hearing disorders, such as tinnitus and age-related hearing loss. The study is published in Nature Communications.